Modulation of CLA, IL-12R, CD40L, and IL-2Rα expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275

• Published in: Cellular immunology 2007-05, Vol.247 (1), p.1-11
• Main Authors: Reddy, Manjula, Davis, Cuc, Wong, Jackson, Marsters, Paul, Pendley, Charles, Prabhakar, Uma
• Format: Article
• Language: English
• Subjects: CNTO 1275; Cytokines; IL-12; IL-17; IL-23; Psoriasis
• ISSN: 0008-8749; 1090-2163
• DOI: 10.1016/j.cellimm.2007.06.006

Cytokines interleukin (IL)-12 and IL-23 are implicated in the pathogenesis of psoriasis. IL-12 causes differentiation of CD4+ T cells to interferon-γ (IFN-γ)-producing T helper 1 (Th1) cells, while IL-23 induces differentiation to IL-17-producing pathogenic Th17 cells. The effects of the monoclonal antibody to IL-12/23 p40 subunit (CNTO 1275) on IL-12 receptor (IL-12R) expression, markers associated with skin homing, activation, and cytokine secretion were investigated in vitro using human peripheral blood mononuclear cells (PBMCs) from healthy donors. PBMCs were activated in the presence or absence of recombinant human (rh) IL-12 or rhIL-23, with or without CNTO 1275. CNTO 1275 inhibited upregulation of CLA, IL-12R, IL-2Rα and CD40L expression and also inhibited IL-12- and IL-23-induced IFN-γ, IL-17A, tumor necrosis factor (TNF)-α, IL-2, and IL-10 secretion. Thus, the therapeutic effect of CNTO 1275 may be attributed to the IL-12/23 neutralization, resulting in decreased expression of skin homing and activation markers, and IL-12- and IL-23-induced cytokine secretion.